<code id='A57B48FDB8'></code><style id='A57B48FDB8'></style>
    • <acronym id='A57B48FDB8'></acronym>
      <center id='A57B48FDB8'><center id='A57B48FDB8'><tfoot id='A57B48FDB8'></tfoot></center><abbr id='A57B48FDB8'><dir id='A57B48FDB8'><tfoot id='A57B48FDB8'></tfoot><noframes id='A57B48FDB8'>

    • <optgroup id='A57B48FDB8'><strike id='A57B48FDB8'><sup id='A57B48FDB8'></sup></strike><code id='A57B48FDB8'></code></optgroup>
        1. <b id='A57B48FDB8'><label id='A57B48FDB8'><select id='A57B48FDB8'><dt id='A57B48FDB8'><span id='A57B48FDB8'></span></dt></select></label></b><u id='A57B48FDB8'></u>
          <i id='A57B48FDB8'><strike id='A57B48FDB8'><tt id='A57B48FDB8'><pre id='A57B48FDB8'></pre></tt></strike></i>

          focus

          focus

          author:focus    Page View:9
          U.S. President Joe Biden stands with his fingers locked next to an US flag — politics coverage from STAT
          President Biden's White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs.

          WASHINGTON — The White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs, its latest effort to draw attention to the program in an election year.

          The news is not controversial: The pharmaceutical companies that make the first ten drugs up for negotiation all submitted counteroffers. It’s an incremental step in the new program, which was created in 2022.

          advertisement

          Earlier this year, Medicare sent its initial price offers to the companies. Neither the Biden administration nor the drug manufacturers have volunteered any information about the White House’s initial price offers or the counteroffers. The process is scheduled to end by Aug. 1.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Maisha Meds is a PBM, but don't call it that
          Maisha Meds is a PBM, but don't call it that

          ZachariahKirimiisapharmacistwhousestheMaishaMedsapptohelpmanagehisinventoryandoffersubsidizedproduct

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          Maisha Meds is a PBM, but don't call it that

          ZachariahKirimiisapharmacistwhousestheMaishaMedsapptohelpmanagehisinventoryandoffersubsidizedproduct